BioMedical Research — research payments reported

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$132,271	18
2024	Research	$73,026	8
2023	Research	$192,194	10
2020	Research	$537	2
2019	Research	$30,023	3

Breakdown

Who paid Research payments · program years 2019–2025

Pfizer Inc. $398,028 38 payments
Bard Peripheral Vascular, Inc. $17,305 1 payment
Provepharm Inc. $11,000 1 payment
Davol Inc. $1,718 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 3 Randomized Placebocontrolled Observerblinded Trial to Evaluate the Safety of A 6Valent Ospabased Lyme Disease Vaccine Vla15 in Healthy Children 5 Through 17 Years of Age $393,329 28 payments
Ultrascore $17,305 1 payment
Pvp201603 $11,000 1 payment
A Phase 3 Protocol to Investigate the Safety Tolerability and Immunogenicity of A Bnt162b2 Lp81adapted Vaccine in Children 5 Through 11 Years of Age Considered at High Risk for Severe Covid19 $3,413 6 payments
Dvl-He-018 $1,718 1 payment
A Phase 3 Randomized Doubleblind Trial to Evaluate the Safety and Immunogenicity of A 20Valent Pneumococcal Conjugate Vaccine in Healthy Infants $537 2 payments
A Phase 3 Randomized Observerblinded Study to Evaluate the Safety Tolerability and Immunogenicity of A Combined Modified Rna Vaccine Candidate Against Covid19 and Influenza in Healthy Individuals $404 1 payment
A Master Phase 123 Protocol to Investigate the Safety Tolerability and Immunogenicity of Bivalent Bnt162b2 Rna Based Vaccine Candidates in Healthy Children $346 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.